These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Impact of Model for End-stage Liver Disease Score-based Allocation System in Korea: A Nationwide Study. Lee J; Kim DG; Lee JY; Lee JG; Joo DJ; Kim SI; Kim MS Transplantation; 2019 Dec; 103(12):2515-2522. PubMed ID: 30985735 [TBL] [Abstract][Full Text] [Related]
29. Donor risk factors in orthotopic liver transplant: analysis of the OPTN/UNOS registry. Kawakita S; Everly MJ Clin Transpl; 2013; ():13-22. PubMed ID: 25095488 [TBL] [Abstract][Full Text] [Related]
30. The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center. Agopian VG; Petrowsky H; Kaldas FM; Zarrinpar A; Farmer DG; Yersiz H; Holt C; Harlander-Locke M; Hong JC; Rana AR; Venick R; McDiarmid SV; Goldstein LI; Durazo F; Saab S; Han S; Xia V; Hiatt JR; Busuttil RW Ann Surg; 2013 Sep; 258(3):409-21. PubMed ID: 24022434 [TBL] [Abstract][Full Text] [Related]
31. Donor-Model for End-Stage Liver Disease and donor-recipient matching in liver transplantation. Vitale A; Ramirez Morales R; dalla Bona E; Scopelliti M; Zanus G; Neri D; d'Amico F; Gringeri E; Russo F; Burra P; Angeli P; Cillo U Transplant Proc; 2011 May; 43(4):974-6. PubMed ID: 21620029 [TBL] [Abstract][Full Text] [Related]
32. Effect of diabetes and acute rejection on liver transplant outcomes: An analysis of the organ procurement and transplantation network/united network for organ sharing database. Kuo HT; Lum E; Martin P; Bunnapradist S Liver Transpl; 2016 Jun; 22(6):796-804. PubMed ID: 26850091 [TBL] [Abstract][Full Text] [Related]
34. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk. Somsouk M; Kornfield R; Vittinghoff E; Inadomi JM; Biggins SW Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185 [TBL] [Abstract][Full Text] [Related]
35. Changes in liver acceptance patterns after implementation of Share 35. Washburn K; Harper A; Baker T; Edwards E Liver Transpl; 2016 Feb; 22(2):171-7. PubMed ID: 26437266 [TBL] [Abstract][Full Text] [Related]
36. Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality. Salvalaggio PR; Afonso RC; Pereira LA; Ferraz-Neto BH Transplant Proc; 2012 Oct; 44(8):2283-5. PubMed ID: 23026574 [TBL] [Abstract][Full Text] [Related]
37. Results of liver transplantation from old donors. Dudek K; Kornasiewicz O; Remiszewski P; Zieniewicz K; Wróblewski T; Krawczyk M Transplant Proc; 2014 Oct; 46(8):2762-5. PubMed ID: 25380912 [TBL] [Abstract][Full Text] [Related]
38. (D+10) MELD as a novel predictor of patient and graft survival after adult to adult living donor liver transplantation. Soin AS; Goja S; Yadav SK; Tamang TY; Rastogi A; Bhangui P; Thiagrajan S; Raut V; Babu RY; Saigal S; Saraf N; Choudhary NS; Vohara V Clin Transplant; 2017 May; 31(5):. PubMed ID: 28239914 [TBL] [Abstract][Full Text] [Related]
39. Detrimental graft survival of size-mismatched graft for high model for end-stage liver disease recipients in liver transplantation. Fukazawa K; Nishida S; Pretto EA; Vater Y; Reyes JD J Hepatobiliary Pancreat Sci; 2016 Jul; 23(7):406-13. PubMed ID: 27108389 [TBL] [Abstract][Full Text] [Related]
40. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list. Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U; J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]